Table 1

Biosimilars for rheumatic diseases for which data have been published in peer-reviewed journals or presented at international scientific meetings

Reference productBiosimilar molecules
AdalimumabABP501
BI 695501
CHS-1420
GP-2017
M923
SB5
ZRC-3197
EtanerceptCHS-0214
GP2015
HD203
SB4*
InfliximabBOW015†
CT-P13*‡
PF-06438179
SB2
RituximabCT-P10
GP2013
PF-05280586
  • *Approved by EMA and multiple other countries.

  • †Approved in India.

  • ‡Recommended for approval by FDA.

  • EMA, European Medicines Agency; FDA, Food and Drug Administration.